BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 2020
View Archived Issues
Lung changes from Parkinson's disease drug candidates are reversible
Read More
Platelets play role in Tylenol toxicity
Read More
Hepatic glutaminase 1 targeting reduces steatosis and decreases oxidative stress in NASH models
Read More
Chimerix initiates phase II/III study of DSTAT in patients with severe COVID-19
Read More
Promising data from compassionate care program of CAP-1002 in critical COVID-19 patients
Read More
Phase I data for SNDX-6352 as monotherapy and in combination with durvalumab presented
Read More
SVC-112 inhibits tumor growth in HNSCC models
Read More
First-in-human data presented for MOv18
Read More
Massachusetts General Hospital and collaborators patent SREBF1 inhibitors
Read More
Glo Pharma synthesizes new nicotinic acetylcholine receptor antagonists
Read More
BAY-2416964: an orally available AhR antagonist for the immunotherapy of advanced solid tumors
Read More
New CDK2/cyclin E inhibitors identifies at Incyte
Read More
Galecto Biotech presents new galectin-3 inhibitors
Read More
Autifony Therapeutics identifies new K(V)3 potassium channel modulators
Read More
Reprogramming microglial functional state has therapeutic potential for AD
Read More
AZD-9833: an orally available SERD presented by AstraZeneca
Read More
Phase II data presented for genolimzumab in peripheral T-cell lymphoma, alveolar soft part sarcoma
Read More
First-in-human data presented for TruUCAR-based GC-027
Read More
European Commission approves Ruconest to treat HAE attacks in children
Read More
Topline data from phase III study of 5- and 10-day dosing regimens of remdesivir in severe COVID-19
Read More
Jazz ends enrollment early in phase III trial of defibrotide for prevention of VOD
Read More
FDA approves Zejula as first-line maintenance for ovarian cancer regardless of biomarker status
Read More
